Cell Therapy Technologies Market Segmentation by Product (Consumables, System & Software, and Equipment); by Process (Process Monitoring & Quality Control, Cell Processing, and Cell Preservation, Distribution & Handling); by Cell Type (T-Cells, Stem Cells, and Other Cells); by End-User {Contract Research Organizations (CROs), Biopharmaceuticals & Biotech Companies, Cell Banks, Research Institutes, and Other End-Users)-Global Demand Analysis & Opportunity Outlook 2020-2030

  • Product Code:
    RP-ID-10352227
  • Published Date:
    2 Dec 2021
  • Region:
    Global
  • Pages:
    212
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-54

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

ccs

Market Overview:

Global Cell Therapy Technologies Market Highlights Over 2020 - 2030

The global cell therapy technologies market is estimated to garner a revenue of USD 45754.6 Million by the end of 2030, by growing at a CAGR of 13.6% over the forecast period, i.e., 2021 - 2030. Moreover, in the year 2020, the market generated a revenue of USD 12902.1 Million. The growth of the market can primarily be attributed to the growing incidences of chronic and infectious diseases worldwide, especially amongst the elderly population, and the growing utilization of cell therapy technologies for the treatment of these chronic and infectious diseases. Cellular therapy is the process of replacement or repair of damaged tissues and cells. In other words, it deals with the transplantation of human cells by using different advanced technologies. The market is also anticipated to grow on account of the growing elderly population worldwide, as these age group is highly prone to getting infected from chronic diseases. According to the statistics by the World Bank, the population aged 65 and above as a share of total population, increased from 6.874% in the year 2000 to 9.318% in the year 2020.

 

Cell Therapy Technologies Market graph

 

Besides this, the increasing number of research and clinical trials that is undergoing in the field of oncology-related cellular therapy, along with the surge in need for newer, better therapies for diseases such as cancer and cardiovascular diseases (CVDs), are also expected to drive the market growth in the coming years. Moreover, rise in focus on precision medicine, along with the increasing advancements registered in the field of cell-based immunotherapies, such as CAR-T therapy, are also expected to generate numerous opportunities for the market growth in the coming years.

Global Cell Therapy Technologies Market Regional Synopsis

Regionally, the global cell therapy technologies market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is anticipated to garner the largest revenue of USD 19957.2 Million by the end of 2030, up from a revenue of USD 5848.5 Million in the year 2020. The growth of the market in the region can primarily be attributed to the increasing growing incidences of chronic diseases in the region, and therefore the rising need for advanced medications developed from cell therapy technologies. According to the statistics by the United States Centers for Disease Control and Prevention (CDC), out of 10 adults, 6 adults have been registered to have a chronic disease in the United States. The market in the region is also anticipated to grow on account of the availability of a strong medical infrastructure in the region, and for the increasing research activities undergone by several healthcare organizations in the region for the development of advanced cell therapy technologies.

 

On the other hand, the market in Europe is expected to garner the second-largest revenue of USD 12448.8 Million by the end of 2030, up from a revenue of USD 3380.4 Million in the year 2020. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, Netherland, and the Rest of Europe. Out of these, the market in Germany is expected to garner the largest revenue of USD 2405.8 Million by the end of 2030, up from a revenue of USD 618.6 Million in the year 2020.

Growth Drivers and Challenges Impacting the Growth of the Global Cell Therapy Technologies Market

Growth Drivers

  • Increasing Incidences of Chronic and Infectious Diseases

  • Rising Research and Clinical Trials in the Field of Cellular Therapy

Challenges

  • High Cost of the Vaccine or Drug Developed from Cell Therapy Technologies

Global Cell Therapy Technologies Market Segmentation Synopsis

The global cell therapy technologies market is segmented by product into consumables, system & software, and equipment. Out of these, the consumables segment is anticipated to garner the largest revenue of USD 17892.6 Million by the end of 2030, up from a revenue of USD 5163.6 Million in the year 2020. Based on process, the market is segmented into process monitoring & quality control, cell processing, cell preservation, distribution, & handling. Out of these, the cell processing segment is anticipated to garner the largest revenue of USD 20663.3 Million by the end of 2030, up from a revenue of USD 5967.0 Million in the year 2020. On the basis of cell type, the market is segmented into T-cells, stem cells, and other cells. Out of these, the T-cells segment is anticipated to garner the largest revenue of USD 18846.2 Million by the end of 2030, up from a revenue of USD 5389.5 Million in the year 2020. The market is also segmented on the basis of end-user into contract research organizations (CROs), biopharmaceuticals & biotech companies, cell banks, research institutes, and other end-users. Out of these, the biopharmaceuticals & biotech companies' segment is anticipated to generate the largest revenue of USD 16510.1 Million by the end of 2030, up from a revenue of USD 4605.8 Million in the year 2020.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cell therapy technologies market that are included in our report are Lonza Group Ltd., Sartorius AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Avantor, Inc., Eppendorf SE, Miltenyi Biotec B.V. & Co. KG, and others.

Latest Developments in the Global Cell Therapy Technologies Market

  • October 28th, 2021: Avantor, Inc. announced that it has opened a new single-use facility in Hillegom, Netherlands. This newly added facility will add significant value to the overall cleanroom capacity of the company in the European region.

  • September 27th, 2021: Sartorius AG announced that by late 2023, it would be opening a new 130,000 sq. ft state-of-the-art plant in Ann Arbor, Michigan, United States.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.

  • The report includes detailed company profiles of the major players dominating the market.

  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.

  • We provide customized reports as per the clients' requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.


Geography Analysis:


The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analys  & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook

.

FREQUENTLY ASKED QUESTIONS

 1.      Introduction

1.1.  Market Definition

1.2.Market Segmentation

2.    Assumptions

3.    Research Methodology

3.1.Research Process

3.2.                    Primary Research

3.3.                    Secondary Research

4.    Executive Summary – Global Cell Therapy Technologies Market

5.     Market Dynamics

5.1. Market Drivers

5.2.                     Market Trends

6.    Key Market Opportunities

7.     Major Roadblocks for the Market Growth

8.    Regulatory and Standards Landscape

9.    Industry Risk Analysis

10.            Pricing Analysis of Cell therapy Technologies Market

11.  Value Chain Analysis

12.Impact of COVID-19 on the Cell Therapy Technologies Market

13.Market Share Analysis Based on Therapy

14.Competitive Positioning

15. Competitive Landscape

15.1.                  Market Share Analysis, 2020

15.2.                 Competitive Benchmarking

15.3.                 Company Profiles

15.3.1.                      Lonza Group Ltd.

15.3.2.                     Sartorius AG

15.3.3.                     Danaher Corporation

15.3.4.                     Becton

15.3.5.                     Dickinson and Company

15.3.6.                     Thermo Fisher Scientific Inc.

15.3.7.                     Avantor, Inc.

15.3.8.                     Eppendorf SE

15.3.9.                     Miltenyi Biotec B.V. & Co. KG

16.KOL Mapping

17. Bioreactors Market Analysis w.r.t. Product, Region, and Year

18.Future Forecast of the Manufactures and Startup Companies

19.Global Cell Therapy Technologies Market 2020-2030

19.1.                  Market Overview

19.2.                By Value (USD Million)

20.          Global Cell Therapy Technologies Market – Segmentation analysis 2020-2030

20.1.                Product

20.1.1.                     Consumables, 2020-2030F (USD Million)

20.1.2.                    System & Software, 2020-2030F (USD Million)

20.1.3.                    Equipment, 2020-2030F (USD Million)

20.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)

20.1.3.2.                        Single-Use Equipment, 2020-2030F (USD Million)

20.1.3.3.                        Other Cell Therapy Equipment, 2020-2030F (USD Million)

20.2.              Process

20.2.1.                    Process Monitoring and Quality Control, 2020-2030F (USD Million)

20.2.2.                  Cell Processing, 2020-2030F (USD Million)

20.2.3.                  Cell Preservation, distribution and Handling, 2020-2030F (USD Million)

20.3.              Cell Type

20.3.1.                    T-Cells, 2020-2030F (USD Million)

20.3.2.                  Stem Cells, 2020-2030F (USD Million)

20.3.3.                  Other Cells, 2020-2030F (USD Million)

20.4.              End-User

20.4.1.                    Contract Research Organizations (CROs), 2020-2030F (USD Million)

20.4.2.                  Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)

20.4.3.                  Cell banks, 2020-2030F (USD Million)

20.4.4.                  Research institutes, 2020-2030F (USD Million)

20.4.5.                   Other End-Users, 2020-2030F (USD Million)

20.5.               Region

20.5.1.                    North America, 2020-2030F (USD Million)

20.5.2.                   Europe, 2020-2030F (USD Million)

20.5.3.                   Asia Pacific, 2020-2030F (USD Million)

20.5.4.                   Latin America, 2020-2030F (USD Million)

20.5.5.                   Middle East & Africa, 2020-2030F (USD Million)

21.North America Therapy Technologies Market – Segmentation analysis 2020-2030

21.1.                  Product

21.1.1.                       Consumables, 2020-2030F (USD Million)

21.1.2.                      System & Software, 2020-2030F (USD Million)

21.1.3.                      Equipment, 2020-2030F (USD Million)

21.1.3.1.   Cell Processing Equipment, 2020-2030F (USD Million)

21.1.3.2.  Single-Use Equipment, 2020-2030F (USD Million)

21.1.3.3.  Other Cell Therapy Equipment, 2020-2030F (USD Million)

21.2.                Process

21.2.1.                      Process Monitoring and Quality Control, 2020-2030F (USD Million)

21.2.2.                    Cell Processing, 2020-2030F (USD Million)

21.2.3.                    Cell Preservation, distribution and Handling, 2020-2030F (USD Million)

21.3.                Cell Type

21.3.1.                      T-Cells, 2020-2030F (USD Million)

21.3.2.                    Stem Cells, 2020-2030F (USD Million)

21.3.3.                    Other Cells, 2020-2030F (USD Million)

21.4.                End-User

21.4.1.                      Contract Research Organizations (CROs), 2020-2030F (USD Million)

21.4.2.                    Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)

21.4.3.                    Cell banks, 2020-2030F (USD Million)

21.4.4.                    Research institutes, 2020-2030F (USD Million)

21.4.5.                     Other End-Users, 2020-2030F (USD Million)

21.5.                 Country

21.5.1.                      United States, 2020-2030F (USD Million)

21.5.2.                     Canada, 2020-2030F (USD Million)

22.           Europe Therapy Technologies Market – Segmentation analysis 2020-2030

22.1.                Product

22.2.               Process

22.3.               Cell-Type

22.4.               End-User

22.5.               Country

22.5.1.                     Germany

22.5.2.                   United Kingdom

22.5.3.                   France

22.5.4.                   Italy

22.5.5.                    Spain

22.5.6.                   Russia

22.5.7.                    Netherland

22.5.8.                   Rest of Europe

23.           Asia Pacific Technologies Market – Segmentation analysis 2020-2030

23.1.                Product

23.2.               Process

23.3.               Cell-Type

23.4.               End-User

23.5.               Country

23.5.1.                     China

23.5.2.                   India

23.5.3.                   Japan

23.5.4.                   South Korea

23.5.5.                    Australia

23.5.6.                   Singapore

23.5.7.                    Rest of APAC

24.           Latin America Technologies Market – Segmentation analysis 2020-2030

24.1.                Product

24.2.               Process

24.3.               Cell-Type

24.4.               End-User

24.5.               Country

24.5.1.                     Brazil

24.5.2.                   Argentina

24.5.3.                   Mexico

24.5.4.                   Rest of LATAM

25.           Middle East & Africa Technologies Market – Segmentation analysis 2020-2030

25.1.                 Product

25.2.               Process

25.3.               Cell-Type

25.4.               End-User

25.5.                Country

25.5.1.                     GCC

25.5.2.                    Israel

25.5.3.                    South Africa

25.5.4.                    Rest of MEA

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
  1. Lonza Group Ltd.
  2. Sartorius AG
  3. Danaher Corporation
  4. Becton
  5. Dickinson and Company
  6. Thermo Fisher Scientific Inc.
  7. Avantor, Inc.
  8. Eppendorf SE
  9. Miltenyi Biotec B.V. & Co. KG
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports